{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:32:06Z","timestamp":1770820326503,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejim.2020.05.001","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T11:21:39Z","timestamp":1589196099000},"page":"31-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Bleeding risk comparison between direct oral anticoagulants at doses approved for atrial fibrillation and aspirin: systematic review, meta-analysis and meta-regression"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6657-5665","authenticated-orcid":false,"given":"Dimitrios","family":"Sagris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Leventis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7661-5253","authenticated-orcid":false,"given":"Georgios","family":"Georgiopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Korompoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Makaritsis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Vemmos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haralampos","family":"Milionis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0629-9248","authenticated-orcid":false,"given":"George","family":"Ntaios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2020.05.001_bib0001","first-page":"e199","article-title":"AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of cardiology\/American heart association task force on practice guidelines and the heart rhythm society","volume":"130","author":"January","year":"2014","journal-title":"Circulation. 2014"},{"key":"10.1016\/j.ejim.2020.05.001_bib0002","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nrcardio.2011.112","article-title":"The role of aspirin for stroke prevention in atrial fibrillation","volume":"8","author":"Lip","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ejim.2020.05.001_bib0003","first-page":"527","article-title":"Final results","volume":"84","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2020.05.001_bib0004","first-page":"2893","article-title":"ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J 2016"},{"key":"10.1016\/j.ejim.2020.05.001_bib0005","article-title":"AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation","author":"January","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2020.05.001_bib0006","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation: chest guideline and expert panel report","volume":"154","author":"Lip","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2020.05.001_bib0007","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/STROKEAHA.118.023959","article-title":"Disparities and temporal trends in the use of anticoagulation in patients with ischemic stroke and atrial fibrillation","volume":"50","author":"Sur","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2020.05.001_bib0008","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/clc.22936","article-title":"Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program","volume":"41","author":"McIntyre","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ejim.2020.05.001_bib0009","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jacc.2016.11.061","article-title":"The changing landscape for stroke prevention in AF: findings from the GLORIA-AF registry phase 2","volume":"69","author":"Huisman","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2020.05.001_bib0010","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/europace\/euw073","article-title":"Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the global registry on long-term oral antithrombotic treatment in patients with atrial fibrillation (GLORIA-AF) Phase I cohort","volume":"18","author":"Huisman","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.ejim.2020.05.001_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2015.07.013","article-title":"Antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation: the GLORIA-AF registry, Phase II","volume":"128","author":"Huisman","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2020.05.001_bib0012","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1177\/1747493018772722","article-title":"20-year trends of characteristics and outcomes of stroke patients with atrial fibrillation","volume":"13","author":"Ntaios","year":"2018","journal-title":"Int J Stroke"},{"key":"10.1016\/j.ejim.2020.05.001_bib0013","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0735-1097(19)31016-2","article-title":"Oral anticoagulation underused and aspirin overused for atrial fibrillation with advanced chronic kidney disease status","volume":"73","author":"Dorsch","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2020.05.001_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018905","article-title":"Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry","volume":"8","author":"Apenteng","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejim.2020.05.001_bib0015","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/eurheartj\/ehx730","article-title":"Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry","volume":"39","author":"Verheugt","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2020.05.001_bib0016","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jacc.2016.11.061","article-title":"The changing landscape for stroke prevention in AF: findings from the GLORIA-AF registry Phase 2","volume":"69","author":"Huisman","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2020.05.001_bib0017","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1378\/chest.13-2443","article-title":"Stroke\/thromboembolism and intracranial hemorrhage in a real-world atrial fibrillation population: the complications of atrial fibrillation in the Bologna Area (CAFBO) study","volume":"146","author":"Palareti","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2020.05.001_bib0018","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/heartjnl-2016-309832","article-title":"Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation","volume":"103","author":"Camm","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.ejim.2020.05.001_bib0019","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in Patients with Atrial Fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2020.05.001_bib0020","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa1700518","article-title":"Rivaroxaban or aspirin for extended treatment of venous thromboembolism","volume":"376","author":"Weitz","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2020.05.001_bib0021","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source","volume":"378","author":"Hart","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2020.05.001_bib0022","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Dabigatran for prevention of stroke after embolic stroke of undetermined source","volume":"380","author":"Diener","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2020.05.001_bib0023","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2020.05.001_bib0024","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/CIRCULATIONAHA.117.031658","article-title":"Oral anticoagulation in very elderly patients with atrial fibrillation: a nationwide cohort study","volume":"138","author":"Chao","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2020.05.001_bib0025","doi-asserted-by":"crossref","DOI":"10.1111\/jgs.15956","article-title":"Comparisons between oral anticoagulants among older nonvalvular atrial fibrillation patients","author":"Deitelzweig","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ejim.2020.05.001_bib0026","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/jgs.12799","article-title":"New oral anticoagulants in elderly adults: evidence from a meta-analysis of randomized trials","volume":"62","author":"Sardar","year":"2014","journal-title":"J Am Geriatr Soc"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620520301862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620520301862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:32:10Z","timestamp":1760607130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620520301862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":26,"alternative-id":["S0953620520301862"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2020.05.001","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bleeding risk comparison between direct oral anticoagulants at doses approved for atrial fibrillation and aspirin: systematic review, meta-analysis and meta-regression","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2020.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}